时间到事件建模用于预测 Osimertinib 作为一线和二线治疗的存活率
Sungjae Lee1,2, Heungjo Kim1,2, Hongjae Lee1,2
1Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon 21983, Republic of Korea.
Journal of clinical medicine
|June 26, 2025
概括
这项研究使用时间到事件模型预测了Osimertinib在非小细胞肺癌 (NSCLC) 的存活率. 结果显示,Osimertinib的生存率有所改善,在有效性方面有显著的种族差异.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物统计学 生物统计学
背景情况:
- 奥西默提尼布是一种针对特定非小细胞肺癌 (NSCLC) 突变的向疗法.
- 预测长期生存结果对于治疗计划和患者咨询至关重要.
研究的目的:
- 预测奥西默蒂尼布作为NSCLC的第一线和第二线治疗的整体存活率 (OS) 和无进展存活率 (PFS).
- 使用已建立的时间到事件建模技术分析生存数据.
主要方法:
- 随机临床试验 (RCT) 的系统性文献审查在PubMed和Cochrane图书馆到2023年5月.
- 从相关RCT中提取OS和PFS的卡普兰-梅尔曲线.
- 应用图形重建算法和时间到事件模型 (韦布尔,逻辑逻辑) 进行生存预测.
主要成果:
- 预测中位数的生存期:36.35个月 (一线) 和27.46个月 (二线).
- 预测PFS中位数:18.11个月 (第一线) 和10.35个月 (第二线).
- 预测的5年生存率:23% (第一线),非亚洲患者的比率更高.
结论:
- 时间到事件模型准确地预测了osimertinib在NSCLC的生存结果.
- 观察到的治疗疗效的种族差异表明,个性化治疗方法可能是有益的.
相关概念视频
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Actuarial Approach
140
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
140
Comparing the Survival Analysis of Two or More Groups
302
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
302
Kaplan-Meier Approach
281
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
281
Introduction To Survival Analysis
409
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
409
Assumptions of Survival Analysis
200
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
200


